A leading Virginia health center advocate published an op-ed late last week blasting Gov. Glenn Youngkin (R) for choosing “Big [...] …
Category: Providers
The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major New York City hospital reported that decreased 340B pharmacy revenue helped drive millions in year-over-year losses in one [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...] …